Violaine Plante-Bordeneuve
Overview
Explore the profile of Violaine Plante-Bordeneuve including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
88
Citations
4412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vila A, Moktefi A, Damy T, Plante-Bordeneuve V, Remy P, Colombat M, et al.
Amyloid
. 2025 Mar;
:1-4.
PMID: 40045591
No abstract available.
2.
Volpentesta E, Kharoubi M, Donadio C, Rebiai K, Fanen P, Funalot B, et al.
ESC Heart Fail
. 2024 Jul;
11(6):3814-3832.
PMID: 39021317
Aims: Transthyretin cardiac amyloidosis (ATTR-CM) may be an underestimated cause of heart failure among geriatric patients and represent a unique phenotype and prognostic profile. Methods And Results: This retrospective, observational,...
3.
Matthys A, Bardel B, Le Bras F, Creange A, Nordine T, Gounot R, et al.
Eur J Neurol
. 2024 Mar;
31(7):e16285.
PMID: 38511878
Background And Purpose: Peripheral neuropathy is a frequent complication of brentuximab vedotin (BV), used in CD30+ lymphoma treatment. Classic BV-induced neuropathy (BV-CN) is a mild distal sensory axonal polyneuropathy. Severe...
4.
Vutrisiran: a new drug in the treatment landscape of hereditary transthyretin amyloid polyneuropathy
Plante-Bordeneuve V, Perrain V
Expert Opin Drug Discov
. 2024 Jan;
19(4):393-402.
PMID: 38281068
Introduction: Hereditary transthyretin (ATTRv) amyloidosis is a progressive, fatal disorder caused by mutations in the transthyretin (TTR) gene leading to deposition of the misfolded protein in amyloid fibrils. The main...
5.
Gentile L, Diemberger I, Plante-Bordeneuve V, Mazzeo A, Dori A, Luigetti M, et al.
PLoS One
. 2024 Jan;
19(1):e0292435.
PMID: 38241252
Transthyretin amyloidosis (ATTR amyloidosis) is a progressive, multi-systemic disease with wild-type (ATTRwt) and hereditary (ATTRv) forms. Over 130 variants associated with ATTRv amyloidosis have been identified, although little is known...
6.
Gentile L, Coelho T, Dispenzieri A, Conceicao I, Waddington-Cruz M, Kristen A, et al.
Orphanet J Rare Dis
. 2023 Nov;
18(1):350.
PMID: 37946256
Background: Transthyretin amyloidosis (ATTR amyloidosis) is a progressive, multisystemic, life-threatening disease resulting from the deposition of variant or wild-type (ATTRwt amyloidosis) transthyretin amyloid fibrils in various tissues and organs. Methods:...
7.
Damy T, Zaroui A, de Tournemire M, Kharoubi M, Gounot R, Galat A, et al.
Arch Cardiovasc Dis
. 2023 Aug;
116(10):433-446.
PMID: 37640624
Background: Early cardiac amyloidosis (CA) diagnosis enables patients to access effective treatments for better long-term outcomes, yet it remains under-recognised, misdiagnosed and inadequately managed. Aim: To reduce diagnostic delays, we...
8.
Alarcon F, Plante-Bordeneuve V, Nuel G
PLoS One
. 2023 Aug;
18(8):e0288958.
PMID: 37561731
In genetic diseases with variable age of onset, an accurate estimation of the survival function for the mutation carriers and also modifying factors effects estimations are important for the management...
9.
Coelho T, Dispenzieri A, Grogan M, Conceicao I, Waddington-Cruz M, Kristen A, et al.
Amyloid
. 2023 Jul;
30(4):445-448.
PMID: 37459334
No abstract available.
10.
Plante-Bordeneuve V, Gorram F, Olsson M, Anan I, Mazzeo A, Gentile L, et al.
Amyloid
. 2023 Mar;
30(3):313-320.
PMID: 36994840
Background: In hereditary transthyretin amyloidosis (ATTRv), early manifestation and age at onset (AO) may vary strikingly. We assessed the disease'risk (penetrance), AO and initial features in ATTRv families to gain...